uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted December 07, 2014

FDA Raises Concerns Over Generic ADHD Drugs

On November 13, 2014, the U.S. FDA expressed concerns about whether two approved generic versions of Concerta tablets (methylphenidate hydrochloride extended-release tablets), used to treat attention-deficit hyperactivity disorder in adults and children, are therapeutically equivalent to the brand-name drug. The two approved generic versions of Concerta in question are manufactured by Mallinckrodt Pharmaceuticals and Kudco Ireland Ltd.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at